Advances and recent developments in asthma in 2020

L Cevhertas, I Ogulur, DJ Maurer, D Burla, M Ding… - Allergy, 2020 - Wiley Online Library
In this review, we discuss recent publications on asthma and review the studies that have
reported on the different aspects of the prevalence, risk factors and prevention, mechanisms …

Mechanisms of allergen-specific immunotherapy and allergen tolerance

UC Kucuksezer, C Ozdemir, L Cevhertas… - Allergology …, 2020 - jstage.jst.go.jp
abstract Allergen-specific immunotherapy (AIT) is the mainstay treatment for the cure of
allergic disorders, with depicted efficacy and safety by several trials and meta-analysis. AIT …

Food allergy and hypersensitivity reactions in children and adults—A review

SG Tedner, A Asarnoj, H Thulin… - Journal of internal …, 2022 - Wiley Online Library
Adverse reactions after food intake are commonly reported and a cause of concern and
anxiety that can lead to a very strict diet. The severity of the reaction can vary depending on …

The burden of childhood asthma by age group, 1990–2019: a systematic analysis of global burden of disease 2019 data

D Zhang, J Zheng - Frontiers in Pediatrics, 2022 - frontiersin.org
Background Asthma is a common respiratory disease in children. We aimed to update
information about the incidence and mortality and disability-adjusted life years (DALYs) of …

Molecular allergology and its impact in specific allergy diagnosis and therapy

D Barber, A Diaz‐Perales, MM Escribese… - Allergy, 2021 - Wiley Online Library
Progressive knowledge of allergenic structures resulted in a broad availability of allergenic
molecules for diagnosis. Component‐resolved diagnosis allowed a better understanding of …

[HTML][HTML] Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

C Benito-Villalvilla, M Pérez-Diego, A Angelina… - Journal of Allergy and …, 2022 - Elsevier
Background Allergoid–mannan conjugates are novel vaccines for allergen-specific
immunotherapy being currently assayed in phase 2 clinical trials. Allergoid–mannan …

Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?

I Annesi‐Maesano, L Cecchi, B Biagioni, KF Chung… - Allergy, 2023 - Wiley Online Library
Limited number of studies have focused on the impact of pollen exposure on asthma. As a
part of the EAACI Guidelines on Environment Science, this first systematic review on the …

Allergen immunotherapy: the growing role of observational and randomized trial “Real‐World Evidence”

G Paoletti, D Di Bona, DK Chu, D Firinu, E Heffler… - Allergy, 2021 - Wiley Online Library
Background Although there is a considerable body of knowledge about allergen
immunotherapy (AIT), there is a lack of data on the reliability of real‐world evidence (RWE) …

Mechanisms of allergen immunotherapy and potential biomarkers for clinical evaluation

UM Sahiner, M Giovannini, MM Escribese… - Journal of Personalized …, 2023 - mdpi.com
Allergen-immunotherapy (AIT) is an efficacious and disease-modifying treatment option for
IgE-mediated diseases. Among these allergic rhinitis, insect venom allergy, food allergy, and …

Allergic rhinitis: a review

JA Bernstein, JS Bernstein, R Makol, S Ward - JAMA, 2024 - jamanetwork.com
Importance Allergic rhinitis affects an estimated 15% of the US population (approximately 50
million individuals) and is associated with the presence of asthma, eczema, chronic or …